Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and Tolerability of High-Flow Nasal Cannula Oxygen Therapy for Hypoxemic Respiratory Failure in Patients with Interstitial Lung Disease with Do-Not-Intubate Orders: A Retrospective Single-Center Study.
Koyauchi T, Hasegawa H, Kanata K, Kakutani T, Amano Y, Ozawa Y, Matsui T, Yokomura K, Suda T. Koyauchi T, et al. Among authors: yokomura k. Respiration. 2018;96(4):323-329. doi: 10.1159/000489890. Epub 2018 Jun 28. Respiration. 2018. PMID: 29954000 Free article.
Efficacy of corticosteroid and intravenous cyclophosphamide in acute exacerbation of idiopathic pulmonary fibrosis: A propensity score-matched analysis.
Hozumi H, Hasegawa H, Miyashita K, Yasui H, Suzuki Y, Kono M, Karayama M, Furuhashi K, Hashimoto D, Enomoto N, Fujisawa T, Inui N, Nakamura Y, Yokomura K, Nakamura H, Suda T. Hozumi H, et al. Among authors: yokomura k. Respirology. 2019 Aug;24(8):792-798. doi: 10.1111/resp.13506. Epub 2019 Feb 25. Respirology. 2019. PMID: 30803100 Free article.
Pulse oximetric saturation to fraction of inspired oxygen (SpO2/FIO2) ratio 24 hours after high-flow nasal cannula (HFNC) initiation is a good predictor of HFNC therapy in patients with acute exacerbation of interstitial lung disease.
Koyauchi T, Yasui H, Enomoto N, Hasegawa H, Hozumi H, Suzuki Y, Karayama M, Furuhashi K, Fujisawa T, Nakamura Y, Inui N, Yokomura K, Suda T. Koyauchi T, et al. Among authors: yokomura k. Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620906327. doi: 10.1177/1753466620906327. Ther Adv Respir Dis. 2020. PMID: 32046604 Free PMC article.
Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trial.
Fujisawa T, Hozumi H, Kamiya Y, Kaida Y, Akamatsu T, Kusagaya H, Satake Y, Mori K, Mikamo M, Matsuda H, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T. Fujisawa T, et al. Among authors: yokomura k. Respirology. 2021 Apr;26(4):370-377. doi: 10.1111/resp.13978. Epub 2020 Nov 11. Respirology. 2021. PMID: 33179395 Free article. Clinical Trial.
Effects of different high-flow nasal cannula flow rates on swallowing function.
Arizono S, Oomagari M, Tawara Y, Yanagita Y, Machiguchi H, Yokomura K, Katagiri N, Nonoyama ML, Tanaka T. Arizono S, et al. Among authors: yokomura k. Clin Biomech (Bristol, Avon). 2021 Oct;89:105477. doi: 10.1016/j.clinbiomech.2021.105477. Epub 2021 Sep 6. Clin Biomech (Bristol, Avon). 2021. PMID: 34555543
Geriatric Nutritional Risk Index is a predictor of tolerability of antifibrotic therapy and mortality risk in patients with idiopathic pulmonary fibrosis.
Mochizuka Y, Suzuki Y, Kono M, Hasegawa H, Hashimoto D, Yokomura K, Inoue Y, Yasui H, Hozumi H, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Nakamura H, Suda T. Mochizuka Y, et al. Among authors: yokomura k. Respirology. 2023 Aug;28(8):775-783. doi: 10.1111/resp.14523. Epub 2023 May 23. Respirology. 2023. PMID: 37221050
111 results